The association between high-dose allopurinol and erythropoietin hyporesponsiveness in advanced chronic kidney disease. JOINT-KD study.
Oikawa M, Nishiwaki H, Hasegawa T, Sasaki S, Yazawa M, Miyazato H, Saka Y, Shimizu H, Fujita Y, Murakami M, Uchida D, Kawarazaki H, Omiya S, Sasai F, Koiwa F; JOINT-KD Investigators.
Oikawa M, et al. Among authors: koiwa f.
Nephron. 2024 Feb 9. doi: 10.1159/000535874. Online ahead of print.
Nephron. 2024.
PMID: 38342092